Announcements Trials
Browse Landscape

Phase

Phase 3 4

Status

Completed 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Conditions

Leiomyoma 4Menorrhagia 2

Interventions

relugolix 8ulipristal acetate 7telapristone acetate 7estradiol, norethindrone drug combination 7vilaprisan 6asoprisnil 6Estradiol 5linzagolix 4elagolix 4Norethindrone Acetate 3Leuprolide 3Sugars 2Progestins 2epigallocatechin gallate 1Uterine Myomectomy 1Uterine Artery Embolization 1Tranexamic Acid 1Tea 1Standard of Care 1Sodium Chloride 1Saline Solution 1Misoprostol 1Mifepristone 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Laparoscopy 1Iron 1Hysterectomy 1Goserelin 1Gonadotropin-Releasing Hormone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Leiomyoma × linzagolix × Clear all
NCT05445167 2025-11-25

A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain

Kissei Pharmaceutical Co., Ltd.

Phase 3 Completed
89 enrolled

Leiomyoma

NCT05440383 2025-03-14

A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia

Kissei Pharmaceutical Co., Ltd.

Phase 3 Completed
287 enrolled

Leiomyoma

NCT03070899 2021-06-09

PRIMROSE 1

ObsEva SA

Phase 3 Completed
526 enrolled

Leiomyoma, Menorrhagia

NCT03070951 2021-03-05

PRIMROSE 2

ObsEva SA

Phase 3 Completed
511 enrolled

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡